Gulf International Bank UK Ltd Sells 447 Shares of Humana Inc. (NYSE:HUM)

Gulf International Bank UK Ltd lowered its stake in Humana Inc. (NYSE:HUM) by 4.3% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,866 shares of the insurance provider’s stock after selling 447 shares during the quarter. Gulf International Bank UK Ltd’s holdings in Humana were worth $3,124,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in HUM. Norden Group LLC increased its stake in Humana by 137.9% in the 1st quarter. Norden Group LLC now owns 1,130 shares of the insurance provider’s stock worth $392,000 after buying an additional 655 shares in the last quarter. Leith Wheeler Investment Counsel Ltd. purchased a new stake in shares of Humana during the first quarter worth about $12,607,000. Duality Advisers LP grew its position in shares of Humana by 58.3% during the first quarter. Duality Advisers LP now owns 19,182 shares of the insurance provider’s stock worth $6,651,000 after purchasing an additional 7,068 shares in the last quarter. Empirical Finance LLC raised its stake in Humana by 3.4% during the 1st quarter. Empirical Finance LLC now owns 4,543 shares of the insurance provider’s stock valued at $1,575,000 after purchasing an additional 148 shares during the period. Finally, Envestnet Portfolio Solutions Inc. lifted its holdings in Humana by 137.6% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 4,801 shares of the insurance provider’s stock worth $1,665,000 after purchasing an additional 2,780 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Price Performance

Shares of HUM stock opened at $288.69 on Thursday. The company has a market capitalization of $34.76 billion, a P/E ratio of 25.57, a P/E/G ratio of 1.98 and a beta of 0.52. The company’s 50-day simple moving average is $291.98 and its two-hundred day simple moving average is $333.24. Humana Inc. has a one year low of $213.31 and a one year high of $527.18. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The company had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. As a group, equities analysts anticipate that Humana Inc. will post 16.15 EPS for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Analysts Set New Price Targets

A number of analysts have issued reports on HUM shares. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a report on Thursday, October 3rd. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $395.00 target price on shares of Humana in a report on Tuesday, October 1st. Leerink Partnrs downgraded Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Leerink Partners cut Humana from an “outperform” rating to a “market perform” rating and cut their price target for the company from $400.00 to $250.00 in a report on Wednesday, October 2nd. Finally, Sanford C. Bernstein raised Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective on the stock in a report on Tuesday, October 8th. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.